Evidence map›Paper›PMID 42026332›Full record

ArticleEuropean radiology2026

Quantification of chronic vascular remodeling in sickle cell disease.

Mikaël Leys, Meriem Knani, Alexandre Unger, Nasroola Damry, Sylvain Le Jeune, Catalin Fetita, Pierre-Yves Brillet

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mikaël LeysDepartment of Radiology, Assistance Publique des Hôpitaux de Paris (AP-HP), Centre Hospitalier Universitaire Avicenne, Bobigny, France. mikael.leys@gmail.com.ORCID http://orcid.org/0009-0004-1764-9372
Meriem KnaniDepartment of Radiology, Assistance Publique des Hôpitaux de Paris (AP-HP), Centre Hospitalier Universitaire Avicenne, Bobigny, France.
Alexandre UngerDepartment of Cardiology, Hôpital Universitaire de Bruxelles, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Nasroola DamryDepartment of Radiology, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
Sylvain Le JeuneDepartment of Internal Medicine, Assistance Publique des Hôpitaux de Paris (AP-HP), Centre Hospitalier Universitaire Avicenne, Bobigny, France.
Catalin FetitaSAMOVAR, Telecom SudParis, Institut Polytechnique de Paris, Palaiseau, France.
Pierre-Yves BrilletDepartment of Radiology, Assistance Publique des Hôpitaux de Paris (AP-HP), Centre Hospitalier Universitaire Avicenne, Bobigny, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSickle cell disease (SCD) causes pulmonary parenchymal and vascular complications with a major impact on mortality. Quantitative computed tomography (CT) assessment of pulmonary vascular "pruning" (rarefaction of small-caliber pulmonary vessels) may provide a non-invasive tool to better understand these complications.

objectivesTo evaluate vascular pruning in SCD and its association with clinical, functional respiratory, and imaging parameters. MATERIALS AND

methodsNon-contrast chest CT scans from 73 adult patients with SCD followed at Avicenne Hospital (Paris, France) were analyzed. Pulmonary vascular volumes were quantified using the blood volume in vessels with a cross-sectional area < 5 mm² (BV5) and the ratio of BV5 to total pulmonary blood volume (TBV), measured globally and in peripheral lung regions. These biomarkers were compared with pulmonary function tests (PFTs), CT parenchymal abnormalities, and clinical history of vascular disease.

resultsIn 73 patients (mean age 33 ± 14 years; 38 women), linear opacities (78%), reticulations (53.4%), and proximal vascular abnormalities (pulmonary trunk enlargement and segmental artery dilation: 28.8% and 19.2%, respectively) were significantly associated with reduced BV5 and BV5/TBV, indicating increased pruning. Similar associations were observed in patients with a hemoglobin-corrected diffusing capacity for carbon monoxide (DLCOc) < 80%, history of pulmonary embolism (PE), and pulmonary hypertension (PH). No significant relationship was found with acute vaso-occlusive episodes. Peripheral lung analysis showed trends consistent with global measurements, with some differences in statistical significance.

conclusionPulmonary vascular pruning is observed in SCD in association with parenchymal and vascular abnormalities and may serve as an early imaging biomarker of chronic vasculopathy. KEY POINTS: Question Can automated quantitative analysis of pulmonary vessels on non-contrast chest CT reveal vascular pruning and provide imaging biomarkers of pulmonary vasculopathy in sickle cell disease? Findings CT-derived vascular pruning markers (BV5 and BV5/TBV) were associated with reduced DLCOc, history of pulmonary hypertension or embolism, and parenchymal and vascular abnormalities in SCD. Clinical relevance Quantification of vascular pruning on routine non-contrast chest CT may provide a practical, non-invasive biomarker for detecting pulmonary vasculopathy and identifying sickle cell disease patients at risk for pulmonary hypertension.

Indexed as

Anemia, Sickle CellTomography, X-Ray ComputedVascular RemodelingAdultFemaleHumansLungMaleMiddle AgedRespiratory Function TestsVaso-Occlusive CrisesYoung AdultBiomarkersMultidetector computed tomographyPulmonary circulationSickle cell diseaseVascular remodeling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.